These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12111991)

  • 1. Nuclear matrix proteins as biomarkers in prostate cancer.
    Leman ES; Getzenberg RH
    J Cell Biochem; 2002; 86(2):213-23. PubMed ID: 12111991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer.
    Leman ES; Arlotti JA; Dhir R; Greenberg N; Getzenberg RH
    J Cell Biochem; 2002; 86(2):203-12. PubMed ID: 12111990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of nuclear matrix proteins in the cancer and normal rat prostate.
    Getzenberg RH; Pienta KJ; Huang EY; Coffey DS
    Cancer Res; 1991 Dec; 51(24):6514-20. PubMed ID: 1742724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer.
    Leman ES; Madigan MC; Brünagel G; Takaha N; Coffey DS; Getzenberg RH
    J Cell Biochem; 2003 Feb; 88(3):599-608. PubMed ID: 12532335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer.
    Partin AW; Getzenberg RH; CarMichael MJ; Vindivich D; Yoo J; Epstein JI; Coffey DS
    Cancer Res; 1993 Feb; 53(4):744-6. PubMed ID: 7679049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer-associated nuclear matrix proteins.
    Getzenberg RH; Konety BR; Oeler TA; Quigley MM; Hakam A; Becich MJ; Bahnson RR
    Cancer Res; 1996 Apr; 56(7):1690-4. PubMed ID: 8603421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of nuclear lamins in normal and cancerous prostate tissues.
    Coradeghini R; Barboro P; Rubagotti A; Boccardo F; Parodi S; Carmignani G; D'Arrigo C; Patrone E; Balbi C
    Oncol Rep; 2006 Mar; 15(3):609-13. PubMed ID: 16465420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p300 modulates nuclear morphology in prostate cancer.
    Debes JD; Sebo TJ; Heemers HV; Kipp BR; Haugen DL; Lohse CM; Tindall DJ
    Cancer Res; 2005 Feb; 65(3):708-12. PubMed ID: 15705864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
    Zeng L; Kyprianou N
    Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the nuclear matrix proteins in malignant transformation and cancer diagnosis.
    Sjakste N; Sjakste T; Vikmanis U
    Exp Oncol; 2004 Sep; 26(3):170-8. PubMed ID: 15494683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of AIbZIP and Cdc47 as markers for human prostatic diseases.
    Levesque MH; El-Alfy M; Berger L; Labrie F; Labrie C
    Urology; 2007 Jan; 69(1):196-201. PubMed ID: 17270658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of purine-rich element binding protein (PUR) alpha as a novel treatment target for hormone-refractory prostate cancer.
    Inoue T; Leman ES; Yeater DB; Getzenberg RH
    Prostate; 2008 Jul; 68(10):1048-56. PubMed ID: 18386260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common set of nuclear matrix proteins in prostate cancer cells.
    Pienta KJ; Lehr JE
    Prostate; 1993; 23(1):61-7. PubMed ID: 8337186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: identification of differentially expressed and MAR-binding proteins.
    Barboro P; D'Arrigo C; Repaci E; Bagnasco L; Orecchia P; Carnemolla B; Patrone E; Balbi C
    Exp Cell Res; 2009 Jan; 315(2):226-39. PubMed ID: 19000672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of nuclear matrix protein alterations associated with human colon cancer.
    Brünagel G; Vietmeier BN; Bauer AJ; Schoen RE; Getzenberg RH
    Cancer Res; 2002 Apr; 62(8):2437-42. PubMed ID: 11956108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the value of fine needle aspiration biopsy of the prostate.
    Buhmeida A; Collan Y
    Pathologica; 2001 Jun; 93(3):242-3. PubMed ID: 11433620
    [No Abstract]   [Full Text] [Related]  

  • 20. Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications.
    Barboro P; Rubagotti A; Boccardo F; Carnemolla B; Darrigo C; Patrone E; Balbi C
    Anticancer Res; 2005; 25(6B):3999-4004. PubMed ID: 16309191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.